A plasmid encoding a recombinant human O 6 -methylguanine-DNA methyltransferase (MGMT) fused to a fragment of the bacteriophage XN protein has been constructed. The fusion protein retained methyltransferase activity when expressed at high levels in E.coli and was purified to essential homogeneity by a simple procedure. Antisera raised against the purified fusion protein recognized MGMT in western blots of extracts of human cells. For most cell lines, there was a quantitative relation between the amount of immunologically detectable MGMT protein and enzyme activity. However, four cell lines contained detectable MGMT protein despite having no measurable methyltransferase activity. Additionally, a HeLa line contained considerably more immunoreactive MGMT protein than could be accounted for by its methyltransferase activity. Thus, some cells contain significant amounts of inactive MGMT. Preliminary characterization of the inactive protein in HeLaS3 cells indicated that it has some properties in common with MGMT methylated at the active cysteine residue.
INTRODUCTION
The DNA repair enzyme O 6 -methylguanine (O 6 -MeGua)-DNA methyltransferase (MGMT) protects human cells against the genotoxic effects of a number of important alkylating agents (For reviews see 1,2). In particular, loss of its expression predisposes the cell to killing, and to the induction of mutation and sister chromatid exchanges by methylating agents such as N-methyl-N-nitrosourea (MNU) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Unrepaired O 6 -MeGua in DNA causes G:C to A:T transition mutations as a consequence of its ability to mispair with thymine during DNA replication. G:C to A:T transitions are a predominant feature of some spontaneous mutation spectra (3) and there is some evidence that MGMT acts to prevent this type of spontaneous mutation (Aquilina et al, In press). A possible explanation for the observed protection is that O 6 -MeGua is introduced into DNA, perhaps by an endogenous methylating agent, and that in cells of the MGMT-defective or Mex" (Mer~) phenotype it is a major contributor to spontaneous mutagenesis.
Loss of MGMT activity is commonly associated with cellular transformation. In particular, cell lines derived from tumor biopsies or transformed in vitro frequently exhibit the Mexp henotype. Comparison of enzyme activities indicates that human cell lines can express a wide range of MGMT activity between the extreme Mex + and Mex~ states. In this regard, cell lines in culture reflect the considerable interindividual and intertissue variation in human MGMT activity (4, 5) . Among cultured cells, MGMT gene expression can exhibit a spontaneous instability and consequently the level of MGMT activity for any particular cell population may not be fixed (6, 7) . This instability introduces variability in methyltransferase determinations even in initially clonal cell populations.
An important contributory factor to the loss of MGMT activity is apparently a transcriptional silencing of the MGMT gene since MGMT mRNA is present in Mex + cells but normally undetectable by northern blotting in Mex~ cells (8, 9) . Alterations in the pattern of cytosine methylation of the MGMT gene may play a part in this regulation although the relation between cytosine methylation and MGMT gene silencing is complex: in most Mex~ cell lines the gene is hypomethylated relative to Mex + lines whereas some others exhibit the more usual relationship and MGMT sequences are hypermethylated (10,11, S.Cairns-Smith and P.K., In press). The role of MGMT in protecting against transformation by common alkylating agents, indicates the importance of understanding the factors that control the variability of expression of MGMT activity within cell populations.
The MGMT acts by an unusual mechanism in which a unique activated cysteine residue accepts the methyl group transferred from the methylated base. Methylation of the cysteine residue inactivates the enzyme and active molecules cannot be regenerated. The fate of methylated molecules is not known although there is some evidence to suggest that they might turn over more rapidly than their active counterparts (12) . The suicidal nature of the MGMT reaction indicates that the repair of spontaneously occurring O 6 -MeGua could contribute to the observed variations in active MGMT between cell types. In order to test this possibility, we have used immunoblotting with rabbit antisera raised against a purified recombinant human MGMT to investigate the steady-state level of human MGMT protein in cell extracts. Comparison of MGMT protein and methyltransferase activity in eight Mex + human cell lines indicated a quantitative relation between these two parameters. Both enzyme activity and MGMT protein were undetectable in three Mex~ lines. In contrast, four cell lines were found that exhibited an excess of MGMT protein over methyltransferase activity. Three lymphoid lines and a HeLa line that expressed no detectable MGMT activity and had been designated Mex~, contained significant levels of MGMT protein. In addition, a Mex + HeLaS3 line contained an excess of MGMT protein over methyltransferase activity. These data indicate that inactive MGMT protein may be present in each of these cell types. The active and inactive forms of MGMT in HeLaS3 cells could be resolved by chromatography on phosphocellulose and in this respect the chromatographic behaviour of the inactive protein resembled that of MGMT methylated at the active cysteine.
MATERIALS AND METHODS Chemicals
All chemicals were obtained from BDH and were Analar grade or better. Biochemicals were obtained from Sigma except where specifically stated otherwise. Radiochemicals were from Amersham International. Restriction enzymes (BRL), calf intestinal phosphatase (Boehringer Mannheim), T4 DNA ligase (BRL) and SI nuclease (Boehringer Mannheim) were used in accordance with suppliers' instructions. Protein standards were obtained from Biorad.
Bacterial strains and plasmids
The E.coli strain UT5600recA, and the plasmid pHE6 (13) were kindly provided by Professor L.Grossman. The human MGMT cDNA clone pHM14 (8) was maintained in E.coli JM101. Propagation of bacteria, purification of plasmids, preparation of competent E. coli and manipulation of recombinant DNA were carried out by standard techniques (14) . The human lymphoblastoid cell lines GM2634, GM2485,  GM2344, GM2345, GM2781, GM1646, GM2248, GM0892,  GM0621, GM2498 and GM1953 were obtained from the Human Genetic Mutant Cell Repository, Camden, NJ, USA. GM1953(S) is a Mex~ subline of GM1953 that arose spontaneously in our laboratory (6) . The Burkitt's lymphoma lines Raji and Daudi and the HeLaS3 cell line were obtained from the American Type Culture Collection, Rockville, MD, USA. The Mex" HeLa line, HeLaMR, was kindly provided Dr. M.Bignami.
Human cell lines

Methyltransferase assay
Crude extracts of human cells were prepared by extracting washed cells (lO^ml) in ice-cold Triton Extraction Buffer (50mM TrisHCl, pH 7.5, lmM EDTA, lOmM DTT, 0.2% Triton X-100). Debris were removed by centrifugation (5min, 14000rpm) and the supernatant, which contained 10-20mg protein/ml used for assay. In the standard assay, 0-200/tg extract was added to 100/xl reaction mixture ( -methylguanine in the standard assay.
Construction of recombinant plasmids encoding a human MGMT-X.N fusion protein
The human MGMT cDNA was excised from plasmid pHM14 by digestion with EcoRI and purified by agarose gel electrophoresis. 30ng purified EcoRI fragment were digested with 3 units SI nuclease for lOmin at 37°C in 50mM Na Acetate pH 4.6, lmM ZnCl 2 , 250mM NaCl, 50/tg/ml bovine serum albumin. The reaction was terminated by addition of EDTA (5mM) and the digested cDNA recovered by ethanol precipitation.
Purified pHE6 DNA (700ng) was digested with Smal and dephosphorylated (37 °C, 30min) with calf intestinal phosphatase (0.3 units). Dephosphorylation was terminated by addition of an equal volume of SDS buffer (lOOmM NaCl, lOmM TrisHCl, pH8.0, lmM EDTA, 0.1 % SDS) and heating at 70°C for 15min. After phenol extraction, the SI nuclease digested cDNA and dephosphorylated vector were ligated overnight at 20°C in ligation buffer (66mM Tris-HCl, pH 7.5, 5mM MgCl 2 , 5mM DTT, lmM ATP) containing 400 units T4 DNA ligase.
The ligated DNA was transformed into competent UT5600recA which were plated on LB plates containing ampicillin (100jtg/ml). After growth overnight at 30°C, colonies were transferred to nitrocellulose filters and screened by hybridization using [ 32 P]-labelled MGMT cDNA as probe. A total of nine positively hybridizing colonies was obtained. Partial restriction analysis based on the known map of pHM14 cDNA indicated that three contained the insert in the correct orientation. The three correctly oriented plasmids were designated pNMTl -3. pNMTl was used for further characterization and purification of the recombinant protein.
Characterization of human MGMT-XN fusion protein 10ml cultures of UT56OOrecA:pNMTl in exponential growth were induced by the addition of an equal volume of L broth prewarmed to 54°C and transferred to 42°C. Incubation at this temperature was continued with shaking for a further 60min. Cells were harvested by centrifugation, washed in 50mM TrisHCl, pH 8.0 and disrupted by sonication on ice in 200/tl extraction buffer (50mM TrisHCl, pH 8.0, lmM EDTA, lOmM DTT). Debris were removed by centrifugation, protein concentrations were determined and the supernatant was used to determine methyltransferase activity and for analysis by SDS-PAGE.
SDS PAGE analysis was performed in a Biorad Miniprotean gel apparatus using 12% gels with 5% stacking gels. 30/ig of each cell extract was applied to the gel. Fixed gels were stained with Coomassie blue.
Purification of human MGMT-XN fusion protein
A 201 exponentially growing fermentor culture of UT56O0recA:pNMTl was induced by rapid temperature shift to 42 °C and growth continued for 60min. Harvested cells (20g) were washed and disrupted by grinding with 50g acid-washed sand. This step and all subsequent operations were carried out at 0-4°C. All buffers contained lmM EDTA and 14mM /3-mercaptoethanol. Disrupted cells were extracted with 100ml extraction buffer (50mM TrisHCl, pH 8.0, lOOmM NaCl) by stirring on ice for 30min.
Sand and cell debris were removed by centrifugation at 2k rpm, 5min and subsequently 7k rpm, lOmin. The supernatant was brought to 20% saturation by the slow addition of solid ammonium sulfate (Ultra Pure, BRL Laboratories). Precipitated material was removed by centrifugation (9k rpm, 15min) and the supernatant brought to 60% ammonium sulfate saturation. Precipitated material was recovered by centrifugation (9k rpm, 15min), dissolved in 30ml DNA Cellulose Buffer (20mM Tris • HC1, pH 8.0) and dialysed for 8-12 hours against 3 changes each of 21 of the same buffer. A small precipitate was removed by centrifugation (10k rpm, 20min), and the supernatant (40ml) was applied to a column of single-stranded DNA cellulose (Sigma) (10cmX4cm dia. equilibrated in DNA Cellulose Buffer) at a flow-rate of lOml/hr. Fractions (12ml) were collected. After loading, the column was washed with DNA Cellulose Buffer (400ml) followed by the same buffer containing 0.1M and 0.3M NaCl. Washing was continued in each case until the A 2 8o of column fractions returned to background. Methyltransferase activity was eluted in a subsequent wash with DNA Cellulose Buffer containing 0.5M NaCl. Occasionally, methyltransferase was eluted in both 0.3M NaCl and 0.5M NaCl washes. Since there were no apparent differences between the two activities, they were pooled for subsequent steps.
Active fractions from the DNA cellulose column were pooled (80ml) and concentrated by ultrafiltration through an Amicon YM10 membrane. The concentrated material (6ml) was applied to a pre-calibrated column (100cmx2cm dia.) of AcA54 (LKB) equilibrated in AcA54 Buffer (50mM Tris-HCl, pH 8.0, 200mM NaCl, 5% glycerol). Methyltransferase activity eluted as a single symmetrical peak with an elution volume characteristic of a protein of M r = 2.9.10 4 . Active fractions were pooled, concentrated by ultrafiltration and stored at -20°C. The purification procedure typically yielded approximately 600jtg purified protein with a specific activity of 10 4 methyltransferase units per mg protein.
Partial purification of human MGMT Approximately 2.10
9 Daudi or GM2498 cells were washed with PBSA. All subsequent steps were performed at 0-4°C. Extracts were prepared by resuspension of cells in 50ml Triton Extraction Buffer containing: 50mM Tris-HCl, pH 7.5, lOOmM NaCl, lmM EDTA, 14mM /J-mercaptoethanol, lmM PMSF and leupeptin, chymostatin and pepstatin (all 0.5/tg/ml). Debris were removed by centrifugation (10 4 rpm, 30min). 0.25 volumes of a concentrated slurry of DE52 (Whatman) equilibrated in DE52 Buffer (20mM Tris-HCl, pH 7.5, 50mM NaCl, lmM K 2 HPO 4 , lmM EDTA, lmM DTT, 14mM /3-mercaptoethanol) was added to the supernatant. After thorough mixing, the DE52 was removed by centrifugation (10 3 rpm, 5min). The supernatant was retained and the DE52 washed by resuspension in 20ml DE52 Buffer. Following recentrifugation, the two supernatants were combined and 0.5 volumes of a concentrated slurry of Phosphocellulose PI 1 (Whatman) equilibrated in DE52 Buffer was added. The resulting slurry was stirred gently for 60min. and then poured into a column. The column was washed with DE52 Buffer until the A 280 returned to background and was then eluted with DE52 Buffer supplemented with 0.5M NaCl. For the Daudi cell extract, fractions were assayed for methyltransferase activity. Active fractions were pooled (Pll + pool), dialysed overnight against 3 changes of 11 lmM KPO 4 , pH 7.5, lmM EDTA, 10% glycerol and stored at -20°C. For the Mex~ line GM4298, equivalent fractions of the Pll eluate were pooled, dialysed and stored in an identical fashion (PI 1-pool). Analysis of MGMT in HeLaS3 cells was performed in a similar fashion.
Production of antisera
New Zealand White rabbits were immunized at multiple sites by subcutaneous injection of a total of 100/tg purified MGMT-XN fusion protein in complete Freund's adjuvant. A total of six subsequent immunizations using the same antigen in incomplete Freund's adjuvant were performed at four-weekly intervals. Antibody titers were determined by ELISA using 96-well microtiter plates coated in MGMT-XN fusion protein (16) .
Inununoblotting
Freshly-prepared crude cell extracts were resoved on 12% SDSpolyacrylamide gels in a Biorad Miniprotean apparatus. Immunoblotting was carried out essentially as described by Harlow and Lane (16) . Briefly, transfer to nitrocellulose filters was performed at 4° overnight at 20V. After blocking with 10% horse serum in D Buffer (50mM Tris-HCl pH 7.5, 200mM NaCl, 0.05% NP40) for 2-3 hours at room temperature, filters were exposed to the primary antibody (anti-human MGMT-XN fusion protein antisera) at a dilution of 1:500 in D Buffer containing 10% horse serum for a further 2hr. After washing 5 times with 25ml D Buffer (5-lOmin each wash), filters were subsequently probed with 25ml secondary antibody, 1/tCi [ 125 I]-labelled donkey anti-rabbit IgG (12-14 /*Ci//tg, Amersham International) in D Buffer containing 10% horse serum. Unbound radioactivity was removed by 6-8 changes of 25ml PBSA. Washed filters were exposed to X-ray film. Densitometric analysis was performed on a Molecular Dynamics densitometer.
PCR analysis of MGMT mRNA expression
Whole RNA was prepared by published procedures (14) . First strand cDNA was synthesized from 4/*g RNA with the cDNA Synthesis System Plus (Amersham International) in a reaction volume of 20jil using random hexamer priming. To amplify MGMT sequences, 10/tl cDNA was incubated with 90/il PCR buffer (lOmM Tris-HCl, pH 8.3, 50mM KC1, 0.01% gelatin, 2.5mM MgCl 2 , 0.5mM dNTPs, 10% DMSO) 50pmol oligonucleotide primers and 2.5units Amplitaq (Perkin-Elmer Cetus). Primers corresponding to positions 1 -23 and 438-464 of the published MGMT cDNA sequence (8) were used and amplification was carried out for 40 cycles in a DNA thermal cycler (Perkin Elmer). Each cycle was: 91 °C for lmin, primer annealing for 2min at 60°C, and polymerization at 72°C for 2min. PCR products were separated on 1 % agarose gels and MGMT species were identified by Southern analysis using MGMT cDNA as a probe.
RESULTS
Construction and purification of a human MGMT-XN fusion protein
The full-length human MGMT cDNA excised from the plasmid pHM14 with EcoRI and made blunt-ended by digestion with SI nuclease, was ligated into the Smal site of the expression vector pHE6 bringing the MGMT sequences under the control of the bacteriophage XP L promoter and the temperature-sensitive XcI857 repressor. After transformation into E. coli UT5600recA and selection for resistance to ampicillin, colonies containing MGMT sequences were identified by hybridization to the cDNA. Partial restriction mapping of 9 positive plasmids indicated that 3 contained an apparently unrearranged, full-length MGMT cDNA inserted in the correct orientation. After induction at 42 °C, (17) . Following heat induction, methyltransferase activity increased approximately 100-fold to 220 units/mg protein. Thus the induced MGMT-XN fusion protein is a protein of approximate M r = 31000 and is an active methyltransferase.
The MGMT-XN fusion protein was purified from thermally induced UT5600recA:pNMTl cells in three steps. A 20-60% ammonium sulfate fraction of a crude cell extract was dialysed and applied to single-stranded DNA cellulose. The pNMTl-encoded methyltransferase was retained and could be eluted with buffers containing O.3-O.5M NaCl. Further purification was effected by size fractionation by chromatography on AcA54. This procedure resulted in an essentially homogeneous preparation of MGMT-XN fusion protein purified approximately 200-fold in about 15% yield (Figure 1) .
Antibodies against the MGMT-XN fusion protein
Polyclonal antisera were raised against the purified MGMT-XN fusion protein by repeated immunization of rabbits. Western blotting using the immune serum at a dilution of 1:500 and [
125 I]-labelled anti-IgG was used to quantitate MGMT. Under the standard conditions, the limit of detection of the purified MGMT-XN fusion protein was 0.1-0.2ng (Figure 2a ). This detection limit represents approximately 3.1O 9 MGMT-XN fusion protein molecules.
In order to investigate whether the antibodies against the fusion protein recognized the unmodified human protein, MGMT was partially purified from the Burkitt's lymphoma line Daudi. Nucleic acid and some protein was removed from a crude cell extract by adsorption to DE52. Unbound proteins were applied to phosphocellulose PI 1. MGMT activity was retained by the PI 1 and eluted at high ionic strength (0.5M NaCl). The eluted MGMT was about 5-fold purified. As a negative control, a crude extract of the Mex~ human lymphoblastoid cell line GM2498 which contains <0.05 units/mg MGMT activity, was chromatographed on Pll in an identical fashion. As expected, no MGMT activity was observed in column fractions. The 0.5M NaCl eluate of the column was retained and concentrated.
When the high salt PI 1 eluate from the Mex + Daudi (PI 1 +) and the negative GM2498 cell line (P11-) were analysed by immunoblotting, a major band of approximate M r = 24000 and additional well-resolved minor bands of higher molecular weight were detected in the MGMT-enriched material from Daudi cells. Minor bands were also present in the (P11-) fraction from GM2498 whereas the M r = 24000 band was absent (Figure 2a) . The M r of the human MGMT is 21700 but it normally migrates with an apparent M r = 24000 (8) . Thus the antiserum directed against the MGMT-XN fusion protein recognises the normal human MGMT and the MGMT protein is absent from the Mex~ line GM2498. Under standard conditions, MGMT protein was detectable when a minimum of 2/tg of the PI 1 + pool was applied to the gel. From the specific activity of this partially purified MGMT, we calculate that the minimum detectable level of MGMT is around 5.10 9 -10 10 molecules (assuming all MGMT molecules retain activity). This value is consistent with the detection limit for the MGMT-XN fusion protein and indicates that normal MGMT and fusion protein molecules are recognized with similar efficiencies. The antisera also recognized a protein 'MGMT activity was determined in the standard assay. The values shown here represent the amount of methyltransferase activity in 100/ig cell extract protein applied to the gel. of M r = 24000 in crude extracts of HeLaS3 cells (Figure 2b ). In this case, MGMT protein was detectable in 6/tg crude cell extract. From the specific enzymatic activity, we calculate that this represents approximately 3.10 9 active MGMT molecules. These detection limits are similar to the limit of sensitivity of the standard enzymatic assay.
Immunoprecipitation and enzyme inhibition
Preincubation of homogeneous MGMT-XN fusion protein, partially purified MGMT or crude human cell extracts with serum dilutions in the range 1:10 s to 1:100 did not inactivate the methyltransferase. Similarly, the anti-MGMT antisera in conjunction with protein A did not precipitate the unmethylated or methylated forms of either the fusion protein or normal human MGMT (data not shown). The inability of protein A to precipitate immune complexes between MGMT and the anti-MGMT antibodies may reflect the relatively small size of the MGMT protein. Alternatively, the antibodies may recognize the protein in an unfolded form but not in its native conformation. activity/mg protein). These Mex" cells contain, on average, fewer than 900 active MGMT molecules per cell.
MGMT levels in extracts of human cell lines
An aliquot (100/ig) of each cell extract was analysed by immunoblotting. The partially purified MGMT from Daudi cells (PI 1 +) was included as a positive control. After probing with immune serum, intensely staining bands were observed at positions corresponding to proteins of M r = 24000 and M r = 40000 (Figure 3) . The higher molecular weight band was not correlated with the Mex status of the cells and varied among cell lines with Raji and GM1953 exhibiting the highest intensities. This band was also prominent in blots probed with the preimmune rabbit serum (Figure 4a ) in which Raji and GM1953 extracts were again, in general, more intensely stained. Adsorbtion to DEAE cellulose followed by chromatography on phosphocellulose Pll completely removed the M r = 40000 protein recognised by both pre-immune and immune sera (PI 1 +, Figure 3 ). The proteins of approximate M r = 40000 recognised by both pre-immune and immune sera are therefore probably identical. In numerous blots containing either Mex" or Mex 24000 (Figure 4a ). These data suggest that it is unlikely that any M r = 24000 material detected by the immune serum is derived by proteolysis from the cross-reacting M r = 40000 material. In addition, in experiments carried out over several months, the intensity of the M r = 40000 band was variable between blots probed with either pre-immune or immune serum (compare Figures 3 & 4a,b) and this band was occasionally absent (Figure 4b,c) . Figure 4c shows a comparison of identical samples analysed on successive days using identical reagents in which the M r = 40000 is apparent in the first but is not present in the second blot. In contrast, the M r = 24000 band was only detected by immune serum and was always of a predictable intensity. We conclude that the M r = 24000 protein is immunologically distinct and is not generated by proteolytic degradation of the M r = 40000 protein.
The immunoreactive M r = 24000 protein in crude cell extracts comigrated with the single intense band in the Daudi P11+ sample (Figure 3,4b,c) . This band was present in all extracts from cell lines designated Mex + but was absent from crude extracts of the Mex~ lymphoblastoid lines GM2248, GM0892 and GM2498 (Figure 3,4b) . These properties serve to identify this protein as the MGMT. The amount of MGMT protein was quantitated by densitometric scanning and values from two independent experiments are presented in Table 1 . Since the signal intensity is dependent on factors such as exposure time and radiochemical age of the secondary antibody, each gel included a sample of the Daudi PI 1 + pool and the values of specific activity are normalized to this standard. The intensities of the M r = 24000 MGMT bands relative to the methyltransferase activities in the Mex + cell extracts were in good quantitative agreement with the value for the Daudi PI 1 + pool. In agreement with the absence of methyltransferase activity, MGMT protein was undetectable by densitometric scanning in extracts of GM2248, GMO892 and GM2498.
There were exceptions to the general correlation between methyltransferase activity and level of immunoreactive MGMT protein. Firstly, cell extracts of four designated Mex~ lines: GM0621, HeLaMR, Raji Mex~, GM1953(S) (which is a Mexs ubline of the Mex + lymphoblastoid line GM1953) reproducibly contained immunoreactive protein that comigrated with authentic MGMT protein (Figure 3 ) despite the absence of measurable methyltransferase activity (<0.01units/mg protein). In addition, HeLaS3 and Raji cell extracts contained levels of MGMT protein that were disproportionately high relative to their enzymatic activity ( Table 1 ). The ratio of methyltransferase activity to the level of immunreactive MGMT protein was approximately half the value of the Mex + lymphoblastoid cell lines indicating that as much as 50% of the MGMT protein may be present in an enzymatically inactive form.
Partial characterization of the inactive MGMT in HeLaS3 cells
The active and inactive forms of MGMT were resolved by fractionation of an extract of HeLaS3 cells on phosphocellulose Pll. After removal of the nucleic acids from the crude extract by batchwise adsorption to DE52, the nonadsorbed material was mixed with PI 1 at low ionic strength (0.05M NaCl) and after washing, bound material was eluted with the same buffer containing 500mM NaCl. Fractions were assayed for MGMT activity. The elution profile is shown in Figure 5a . No MGMT activity was detected in the unbound material (Flow Through) and all active MGMT was eluted at high ionic strength (Eluate). Equal volumes of representative column fractions were analysed by western blotting (Figure 5b ). The active methyltransferase in fractions 14-18 of the eluate was detected by the antiserum. In addition MGMT protein was present throughout the flow-through fractions 2-54. Since the column effectively concentrates the active protein into 5 fractions and the inactive protein is uniformly distributed throughout the flow-through fractions, we estimate that the inactive MGMT comprises >50% of the total MGMT protein applied to the column.
Since MGMT is inactivated by methylation, we examined the behaviour of the methylated MGMT protein on PI 1. A crude extract of Daudi cells was divided into two parts. One part was incubated with substrate DNA containing [ -methylguanine in order to inactivate and radioactively label the MGMT while the other part remained untreated. Each sample was then separately adsorbed to DE52 and fractionated on PI 1 as described above. Fractions from the untreated sample were assayed for MGMT activity (Figure 6a ) and analysed by western blotting (Figure 6b ). As was observed for the HeLaS3 cells, >80% of the active MGMT was retained by the PI 1 column and required high ionic strength for elution. Western blotting analysis of FlowThrough and Eluate fractions is shown in Figure 6b . A small amount of immunoreactive material, consistent with a low level of MGMT activity, was present in the Flow-Through fractions but >80% of MGMT protein was coincident with the MGMT activity in the Eluate fractions.
The radioactive methylated protein exhibited different chromatographic behaviour. Aliquots of the Flow-Through and Eluate fractions of the PI 1 column were incubated overnight with Proteinase K to digest the radioactive methylated MGMT to a TCA-soluble form. Figure 7 shows the elution profile of the methylated protein. A small amount of radioactive proteinase Ksensitive material bound to the column and was eluted at high ionic strength, but most of the radioactive material (>80%) eluted in the How-Through along with the majority of the cellular protein. It appears that methylation alters the MGMT protein in such a way as to prevent its binding to PI 1 and that this property is shared by the inactive MGMT in HeLaS3 cells. (9) . We analysed the MGMT mRNA in our Mex~ lines by PCR amplification of MGMT cDNA followed by blotting and probing with the cloned MGMT cDNA. Figure 8 shows that all Mexl ines including HeLaMR, RajiMex" and GM1953(S) contain low but detectable levels of MGMT mRNA by this analysis. As expected, treatment of the RNA with RNase prior to PCR amplification abolished or severely reduced the signal from Mex + RNA and completely eliminated the signal from the Mex' RNA (Figure 8b ). 
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Fraction No. -meGua-containing substrate DNA (50 pmole) and incubated at 37°C for 30min. Nucleic acids, including unreacted substrate, were removed by adsorbtion to DE52 and the unadsorbed material was mixed with Pll and fractionated as described in the legend to i Figure 8 . MGMT mRNA in Mex + and Mex cells. 4jig total RNA was used to synthesize cDNA by random priming. MGMT cDNA was amplified through 40 cycles of the PCR as described in Methods. PCR products were separated on 1 % agarose gels and MGMT sequences were detected by hybridization to [ 32 P]-labelled human MGMT cDNA. 50pg plasmid pHM14 which contains the human MGMT cDNA was included as a positive control for the PCR. A negative control (no cDNA; H 2 O) was also included. MW designates the DNA molecular size markers (BRL; bacteriophage X lkb Ladder), b) The same RNA samples were treated with heat-treated RNase A (10 Kunitz units/ml; Sigma) for 30min, at 37°C, before preparation of cDNA. Products were analysed as above. -methylguanine-containing DNA and represents a sensitivity comparable to those reported for monoclonal or polyclonal antibodies raised against MGMTspecific peptides (19, 20) .
Flow Through Eluate
DISCUSSION
There is a good quantitative relation between the methyltransferase activity and the level of immunoreactive material for several Mex + and Mex" human lymphoblastoid cell lines. In three lines designated Mex", MGMT protein was not detectable by immunological staining. Under the conditions of the assay, this indicates a lower limit of 5000 MGMT molecules per cell although by increasing the amount of cell extract analysed on the gel, a more precise minimum value could be defined. Similar correlations between methyltransferase activity and MGMT immunoreactive protein have recently been observed in human tumor cell lines (19, 20) .
HeLaS3 cells (and also Raji although our data are less extensive for this line) were an exception to the general correlation between methyltransferase activity and level of MGMT protein. These cells contained high levels of both MGMT activity and immunoreactive MGMT protein. However, the level of MGMT protein was higher than could be accounted for by the enzyme activity, suggesting that a fraction of the MGMT protein of these cells is inactive. A comparison of the relative specific activities of the MGMT protein in the Mex + lymphoblastoid and HeLaS3 cell lines indicated that in the latter up to 50% of the MGMT protein may be enzymatically impotent.
MGMT protein was also detectable in four Mex" cell lines: HeLaMR, RajiMex", GM0621 and GM1953(S). These cell lines were otherwise typical of Mex~ lines in that cell extracts contained <0.01 units of active MGMT per mg protein. The MGMT protein in these Mex" extracts was around 10-30% of the levels in Mex + cells whereas enzyme activity was <5% of Mex + values. The absence of immunoreactive material from crude extracts of three other Mex~ lymphoblastoid cell lines suggests that the protein of M r = 24000 in the HeLaMR, RajiMex" and GM1953(S) lines is indeed MGMT protein and not an abundant protein that cross-reacts with MGMT antisera. The absence of detectable enzyme activity indicates that the MGMT protein observed in immunoblots of these three cell lines is also in an inactive form.
Since the steady-state level of MGMT mRNA in Mex" cells, including GM1953(S) and Raij(Mex") (6, 8) , is below the limit of detection by northern blotting, it seems paradoxical that they contain MGMT protein. However, analysis by a more sensitive PCR-based technique has indicated that low but detectable levels of MGMT mRNA may be present in some Mex" cell lines (9,21). Our own experiments using PCR ampliation of MGMT cDNA, although non-quantitative, confirm the presence of MGMT mRNA in a high proportion of Mex lines including HeLaMR, GM1953(S) and Raij(Mex") in which MGMT protein is also detectable.
There are two possible sources of inactive MGMT in cells: inactive MGMT molecules may be synthesized in the nonfunctional state or functional protein may have become inactivated. In the first case, inoperative enzyme would be produced from a mutated MGMT allele, the other allele being perhaps deleted or maintained in a transcriptionally silent state. Some recent evidence indicating that Mex" HeLaMR cells contain a mutated copy of the MGMT gene and produce a slightly truncated MGMT mRNA (21) would be consistent with this idea. In addition, there is considerable evidence to suggest that although the relationship is complex, DNA cytosine methylation underlies the Mex"phenotype (10,11, S.Cairns-Smith and P.K., In Press). It seems possible therefore that a type of allelic exclusion (22) is responsible for the Mex~ phenotype in some cell lines.
A second source of inactive protein is via demethylation of endogenous DNA O 6 -methylguanine by a functional MGMT. This alternative is supported by our observation that the inactive MGMT in HeLaS3 cells shares some of the altered biochemical characteristics of the self-methylated protein. The methyl group donor, S-adenosylmethionine (S-Adomet) can act as a weak alkylating agent (23, 24) . Some Mex" lines, including Raji(Mex~) and GM1953(S), exhibit an unusual generalized hypermethylation of CpG sequences (S.Cairns-Smith and P.K., In Press) that may be associated with increased concentrations of this methyl group donor. Although at normal intracellular concentrations, the amount of O 6 -MeGua introduced into DNA by S-Adomet should be low (23) , it is possible that imbalances in the intracellular concentration of S-Adomet lead to increased non-enzymatic DNA methylation with consequent inactivation of MGMT. While a definitive answer to these questions requires investigation of the presence of S-methylcysteine in the inactive protein, our preliminary biochemical characterization is consistent with its being methylated. The steady-state levels of inactive MGMT protein are low. However, the observation (12) that inactivated MGMT molecules are lost from cells at elevated rates suggests that what we observe might underestimate the amount of inactive MGMT produced in the cell.
In summary, our data obtained using polyclonal antisera against the human MGMT-XN fusion protein extend the quantitative relationship between MGMT activity and protein levels previously observed in human tumor cell lines (19, 20) to a number of in vitro transformed lymphoblastoid lines. In addition, they define a sub-group of cell lines that contain detectable amounts of inactive MGMT protein that has some of the properties of automethylated MGMT.
